Tratamento da dor oncológica: uma revisão sobre desafios, necessidades e tendências para o futuro
DOI:
https://doi.org/10.34119/bjhrv6n2-201Keywords:
dor crônica, oncologia, anestésicosAbstract
A dor crônica no paciente oncológico é um grande desafio ao manejo terapêutico. Diversas são as linhas de tratamento especializado, perfazendo abordagens farmacológicas e não farmacológicas. Objetivou-se avaliar, por meio de uma revisão narrativa de literatura, as principais condutas associadas à cronicidade da dor oncológica. Marcada pela complexidade, a dor crônica é um dos sintomas mais prevalentes em pessoas com câncer. Com o aumento da taxa de sobrevida dos pacientes portadores de neoplasias, surge a necessidade de estabelecer estratégias especializadas, em detrimento da antagônica postura generalizada, que vigora em quase metade dos casos no país. Considerando as principais opções de tratamento analisadas, destaca-se, sobretudo, a utilização demasiada de opioides, os quais, além dos benefícios para a dor, trazem consigo diversos efeitos colaterais. Nessa perspectiva, percebeu-se que o mais adequado é a abordagem multidisciplinar e multiprofissional do paciente, associando diferentes terapêuticas. Entretanto, no que concerne às terapias alternativas existentes, carece-se de estudos para solidificar seu embasamento científico e sua efetividade para complementar e ampliar a terapêutica tradicional, no intuito de melhorar a qualidade e a efetividade do tratamento oferecido aos pacientes.
References
BENNETT, M. I. et al. Standards for the management of cancer‐related pain across Europe—A position paper from the EFIC Task Force on Cancer Pain. European Journal of Pain, v. 23, n. 4, p. 660–668, 6 jan. 2019.
BICEGO, A. et al. Complementary treatment comparison for chronic pain management: A randomized longitudinal study. PLOS ONE, v. 16, n. 8, p. e0256001, 6 ago. 2021.
BLASCO, M. A.; CORDERO, J.; DUNDAR, Y. Chronic Pain Management in Head and Neck Oncology. Otolaryngologic Clinics of North America, v. 53, n. 5, p. 865–875, 1 out. 2020.
BOLAND, J. W.; POCKLEY, A. G. Influence of opioids on immune function in patients with cancer pain: from bench to bedside. British Journal of Pharmacology, v. 175, n. 14, p. 2726–2736, 9 jul. 2017.
BRUERA, E.; KIM, N. K. Cancer Pain. JAMA, v. 290, n. 18, p. 2476, 12 nov. 2003.
CANDIDO, K. D.; KUSPER, T. M.; KNEZEVIC, N. N. New Cancer Pain Treatment Options. Current Pain and Headache Reports, v. 21, n. 2, fev. 2017.
CARESKEY, H.; NARANG, S. Interventional Anesthetic Methods for Pain in Hematology/Oncology Patients. Hematology/Oncology Clinics of North America, v. 32, n. 3, p. 433–445, jun. 2018.
COVELER, A. L. et al. Pancreas Cancer‐Associated Pain Management. The Oncologist, v. 26, n. 6, mai. 2021.
DALAL, S.; BRUERA, E. Pain Management for Patients With Advanced Cancer in the Opioid Epidemic Era. American Society of Clinical Oncology Educational Book, n. 39, p. 24–35, maio 2019.
DENG, G. Integrative Medicine Therapies for Pain Management in Cancer Patients. The Cancer Journal, v. 25, n. 5, p. 343–348, 2019.
JANAH, A. et al. Underprescription of Step III Opioids in French Cancer Survivors With Chronic Pain: A Call for Integrated Early Palliative Care in Oncology. Journal of Pain and Symptom Management, v. 59, n. 4, p. 836–847, abr. 2020.
JOHNSON, M. I. et al. The clinical efficacy of transcutaneous electrical nerve stimulation (TENS) for acute and chronic pain: a protocol for a meta-analysis of randomised controlled trials (RCTs). BMJ Open, v. 9, n. 10, p. e029999, out. 2019.
KOSCIUCZUK, U.; KNAPP, P.; LOTOWSKA-CWIKLEWSKA, A. M. Opioid-induced immunosuppression and carcinogenesis promotion theories create the newest trend in acute and chronic pain pharmacotherapy. Clinics, v. 75, 2020.
LICHTMAN, A. H. et al. Results of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as an Adjunctive Therapy in Advanced Cancer Patients with Chronic Uncontrolled Pain. Journal of Pain and Symptom Management, v. 55, n. 2, p. 179-188.e1, 1 fev. 2018.
LIU, W. C. et al. Multidimensional Treatment of Cancer Pain. Current Oncology Reports, v. 19, n. 2, fev. 2017.
LOVELL, M. R. et al. Effect of Cancer Pain Guideline Implementation on Pain Outcomes Among Adult Outpatients With Cancer-Related Pain. JAMA Network Open, v. 5, n. 2, p. e220060, 21 fev. 2022.
LU, W.; ROSENTHAL, D. S. Oncology Acupuncture for Chronic Pain in Cancer Survivors. Hematology/Oncology Clinics of North America, v. 32, n. 3, p. 519–533, jun. 2018.
MAINDET, C. et al. Strategies of complementary and integrative therapies in cancer-related pain—attaining exhaustive cancer pain management. Supportive Care in Cancer, v. 27, n. 8, p. 3119–3132, 11 maio 2019.
MAGEE, D. et al. Cancer pain: where are we now? Pain Management, v. 9, n. 1, p. 63–79, jan. 2019.
MAO, J. J. et al. Effectiveness of Electroacupuncture or Auricular Acupuncture vs Usual Care for Chronic Musculoskeletal Pain Among Cancer Survivors. JAMA Oncology, v. 7, n. 5, p. 720, 1 maio 2021.
OLDENMENGER, W. H. et al. A systematic review on barriers hindering adequate cancer pain management and interventions to reduce them: A critical appraisal. European Journal of Cancer, v. 45, n. 8, p. 1370–1380, maio 2009.
PORTENOY, R. K.; AHMED, E. Cancer Pain Syndromes. Hematology/Oncology Clinics of North America, v. 32, n. 3, p. 371–386, jun. 2018.
SCARBOROUGH, B. M.; SMITH, C. B. Optimal pain management for patients with cancer in the modern era. CA: A Cancer Journal for Clinicians, v. 68, n. 3, p. 182–196, 30 mar. 2018.
SYRJALA, K. L. et al. Psychological and Behavioral Approaches to Cancer Pain Management. Journal of Clinical Oncology, v. 32, n. 16, p. 1703–1711, jun. 2014.
VAN DEN BEUKEN-VAN EVERDINGEN, M. H. J. et al. Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis. Journal of Pain and Symptom Management, v. 51, n. 6, p. 1070-1090.e9, jun. 2016.
YOON, S. Y.; OH, J. Neuropathic cancer pain: prevalence, pathophysiology, and management. The Korean Journal of Internal Medicine, v. 33, n. 6, p. 1058–1069, 1 nov. 2018.
ZGAIA, A. O. et al. The role of ketamine in the treatment of chronic cancer pain. Clujul Medical, v. 88, n. 4, p. 457–461, 2015.


